Press Releases

Expects 2026 revenue of approximately €16 million to €18 million compared to €14.4 million in revenue in 2025, with a lower non-IFRS adjusted operating loss and increased net assetsCompleted acquisition of Royal Uranium Inc. on July 21, 2026, adding royalty and similar interests in 16 uranium-focused and three natural gas project areas, including exposure to Canada's Athabasca BasinBrightHy Solutions began execution of a 2 MW industrial green hydrogen project in Spain and contributed approximately €369,000 in first-half 2026 engineering revenueAl Shola Gas signed approximately $3.5 million in new LPG engineering subcontracts in the first half of 2026 and, in September 2026, expanded its LPG

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Cipher Digital Inc. (NASDAQ:CIFR) ("Cipher" or the "Company"), a leading developer, owner and operator of industrial-scale data centers, today announced the pricing of its offering of $850.0 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The issuance and sale of the notes are scheduled to settle on October 16, 2026, subject to customary closing conditions. Cipher granted the initial purchasers of the notes a

State Street Corporation (NYSE:STT) reported its third-quarter 2026 financial results today. The news release, presentation and additional financial information can be accessed on State Street’s Investor Relations website, http://investors.statestreet.com. A conference call to discuss the firm’s financial results, outlook and related matters will be held at 11:00 a.m. ET today, Wednesday, October 14, 2026. The call will be open to the public. The conference call will be accessible on State Street’s Investor Relations website, and by telephone at (+1) 800 439 6511 (Participant Passcode: 96234#). Following the conference call, a replay will be available on State Street’s Investor Relation

Morgan Stanley (NYSE:MS) today announced its third quarter 2026 financial results. The results are now available on the Firm’s Investor Relations website at www.morganstanley.com/about-us-ir/earnings-releases. The results will be filed on a Form 8-K with the Securities and Exchange Commission (SEC) on October 14, 2026, which will be available on the SEC’s website at www.sec.gov. A conference call to discuss the results will be held today at 9:30 a.m. (ET). The call will be available at www.morganstanley.com or by dialing 1-844-886-2200 (domestic) and 1-646-307-1096 (international); the passcode is 400700. Playback will be available via webcast on our website. Morgan Stanley is a leading

OKLAHOMA CITY, Oct. 14, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") will host a conference call on Friday, October 30, 2026, to discuss the Company's results for the third quarter ended September 30, 2026. The conference call will begin at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). Prior to the call, the Company will issue a press release announcing its results, which will also be available in the Investor Relations section of the Mammoth website.The call will be webcast live and can be accessed through the Company's website. Participants may also join by dialing +1-201-689-8433 and requesting the Mammoth conference call. Please log i

FF EAI Robotics Ecosystem Inc. (NASDAQ:FFR) (formerly AIxCrypto Holdings, Inc. and AIXC) and Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("FFAI") signed definitive agreements on October 12, 2026, for FFR to acquire FFAI's robotics assets and business in an all-stock transaction. The parties agreed on a valuation of approximately $200 million for FFAI's robotics business and approximately $60 million for FFR on a fully diluted basis. All closings are expected to be completed by the end of October 2026.  FFR will issue shares to FFAI at $2.246 per share, representing a premium of approximately 50% to FFR's closing price of $1.50 on the signing date of October 12, 2026 and approximat

Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("FFAI") and FF EAI Robotics Ecosystem Inc. (NASDAQ:FFR) (formerly AIxCrypto Holdings, Inc. and AIXC) ("FFR") signed definitive agreements on October 12, 2026, for FFR to acquire FFAI’s robotics assets and business in an all-stock transaction. FFR to become the First U.S.-Listed Pure-Play Humanoid and Bionic EAI Robotics Company under the agreement. The parties agreed on a valuation of approximately $200 million for FFAI’s robotics business and approximately $60 million for FFR on a fully diluted basis. The closing is expected to be completed by the end of October 2026. FFR will issue shares to FFAI at $2.246 per share, repres

Mr. Garofola brings public-company legal, governance and compliance experience to Hecate, as the company advances toward its planned Nasdaq listing. Appointment strengthens leadership team with seasoned counsel experienced in complex risk, regulatory matters and high-growth energy-transition businesses. CHICAGO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Hecate Energy LLC ("Hecate" or the "Company"), a leading U.S. developer of utility-scale energy parks, today announced the appointment of Michael J. Garofola as General Counsel, effective September 21, 2026. In his role as General Counsel, Mr. Garofola will manage the Company’s corporate governance, compliance, risk management, strategic transa

FrontView REIT, Inc. (NYSE:FVR) (the "Company", "FrontView", "we", "our", or "us"), today announced that it will release its financial and operating results for the quarter ended September 30, 2026, before the market opens on Thursday, November 5, 2026. The Company will host its earnings conference call and audio webcast on Thursday, November 5, 2026, at 10:00 a.m. Central Time. Conference Call and Webcast To access the live webcast, which will be available in listen-only mode, please visit: https://events.q4inc.com/attendee/972759351. If you prefer to listen via phone, U.S. participants may dial 1-833-461-5787 (toll-free) or 1-585-542-9983, using conference ID 972759351. A replay of th

Arrowhead’s TRiM™ platform achieves clinical validation for delivery of siRNA that crosses the blood-brain barrier after subcutaneous injection ARO-MAPT demonstrates mean cerebrospinal fluid total tau reduction of 73% on Day 105, with a maximum individual reduction of 85%, supporting the potential for quarterly dosing Arrowhead will host a webinar today, October 14, at 2:30 PM ET/11:30 am PT to review additional interim results Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced interim results from an ongoing Phase 1/2a study of ARO-MAPT, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for Alzheimer’s disease an

HAMBURG, Germany and AUSTIN, Texas, Oct. 14, 2026 (GLOBE NEWSWIRE) -- XCHG Limited ("XCharge" or the "Company") (NASDAQ:XCH), a global provider in high-power EV charging solutions, today issued a statement regarding recent volatility in the market price of the Company's American Depositary Shares ("ADSs"). The Company has noted the recent fluctuations in its ADS price and is not aware of any specific reason for these market movements. The Company is focused on executing its business plan, serving its customers and partners, and strengthening its position across its key markets. "We believe that the Company's current market valuation does not reflect its underlying business fundamentals,

TORONTO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company") today announced that five abstracts presented at the 15th Interventional MRI ("iMRI") Symposium in Boston, Massachusetts, reinforce the growing body of evidence supporting the real-world performance, clinical differentiation, and platform expansion potential of the TULSA Procedure™ performed using the TULSA-PRO® system. Collectively, the presentations underscore three important dimensions of TULSA’s progress: Real-world validation: Findings from the CARE Registry and single-center experiences at Mayo Clinic in Florida and Rochester provide complementary evidence of TULSA

Owens Corning (NYSE:OC), a building products leader, is scheduled to announce its third-quarter financial results on Wednesday, November 4, 2026, before the New York Stock Exchange opens. The company will host a call to discuss its financial results at 9 a.m. ET the same day. Webcast https://events.q4inc.com/attendee/401280488 A webcast replay will be available for one year using the same link. Callers Please dial in 10-15 minutes before the conference call is scheduled to begin and use the meeting code 401280488. U.S. and Canada: 1.833.461.5787 Other international locations: +1.585.542.9983 About Owens Corning Owens Corning is a branded building products leader with th

BELVIDERE, NJ, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform, today announced the expansion of its distribution capabilities through UNFI's Mid-Atlantic distribution center, enabling broader availability of its fresh-cut and potted herbs across more than 1,500 retail stores. Under the expanded arrangement, Edible Garden will serve as the primary supplier of fresh-cut and potted herbs at UNFI's Mid-Atlantic distribution center. This expanded role stre

SANTA ANA, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI) will hold a conference call on Thursday, October 22, 2026, at 8:30 a.m. Eastern Time/ 5:30 a.m. Pacific Time to discuss its third quarter 2026 performance, hosted by President & CEO, Edwin Roks, and Executive Vice President & CFO, Dan Boehle. Access to the conference call will be available by clicking on the registration link TTM Technologies, Inc. Third Quarter 2026 Conference Call. Registering participants will receive dial in information and a unique PIN to join the call. Participants can register at any time up to the start of the conference call. The conference call will also be simulcast on the

SUNRISE -1 and SUNRISE-2 Studies to Evaluate Oral VK2735 in Obese Adults with and without Type 2 Diabetes SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of the SUNRISE Phase 3 clinical program for oral VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity.The SUNRISE

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its third quarter 2026 financial results after the close of the U.S. financial markets on Wednesday, October 28, 2026. Company management will host a webcast and conference call at 4:30 p.m. ET to discuss financial results and recent highlights.The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com or by clicking here. The webcast will be archived and available for replay shortly after the conclusion of the call.To access the live call via telephone, dial (888) 506-0062 (domestic) or (

MCLEAN, Va., Oct. 14, 2026 /CNW/ -- Iridium Communications Inc. (NASDAQ:IRDM), a leading provider of global voice, data, aircraft surveillance, and positioning, navigation, and timing (PNT) satellite services, today announced that Altair Semiconductor, a world leader in cellular IoT chips, is integrating Iridium NTN Direct℠ capability into Altair's ALT1350 and next-generation ALT1550 IoT chipset platforms. With terrestrial cellular IoT and Iridium satellite connectivity on a single chipset, device manufacturers, module makers and mobile network operators (MNOs) will be able to extend IoT connectivity beyond the reach of terrestrial networks through the Iridium satellite network, without addi

—Three Late-Breaking Abstracts at CHEST 2026 Deepen Understanding of the Potential of Treprostinil Palmitil Inhalation Powder (TPIP) Across Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)——New Analysis From the Phase 3 ASPEN Study at CHEST 2026 Provides Additional Insights on Bronchiectasis Management——Phase 3b ENCORE Study Findings at IDWeek 2026 Examine Amikacin and Macrolide Resistance Development in Patients With Newly Diagnosed Mycobacterium avium Complex (MAC) Lung Disease—BRIDGEWATER, N.J., Oct. 14, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to del

DALLAS, Oct. 14, 2026 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ:XTIA) ("XTI Aerospace," "XTI" or the "Company"), an aerospace and advanced technology platform and parent company of Drone Nerds, LLC, ("Drone Nerds"), a leading drone solutions platform serving commercial, enterprise and government customers, today announced the appointment of Dr. Allan Evans as a director and Chairman of its Board of Directors. His addition returns the Board to five members. In connection with Dr. Evans' appointment as Chairman, the Board designated Mr. Ornstein as Vice Chairman of the Board."We are very pleased to welcome Allan to XTI's Board," said Jonathan Ornstein, XTI Aerospace's Vice Chairman. "Allan b